Adaptimmune Therapeutics Plc. ADR News

Aktie

WKN: A14SUX ISIN: US00653A1079 US-Symbol: ADAP

0,985 €

+0,035 €

+3,68%

07.06.24 17:19:58

Handeln Depot/Watchlist

Aktienanzahl *

227,12 Mio.

Marktkapitalisierung *

214,47 Mio. €

Streubesitz

Faktor

Originalaktie

GB00BVYV1687

Index-Zugehörigkeit

IR-Website

zur Website

*Stand: 03.01.2024

Adaptimmune Therapeutics Plc. ADR News

11.04.23 - PR Newswire

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR PR Newswire

06.04.23 - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR PR Newswire

28.03.23 - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR PR Newswire

23.03.23 - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR PR Newswire

07.03.23 - PR Newswire

INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC

INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC PR Newswire

14.03.22 - PR Newswire

Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia?

Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia? PR Newswire

15.09.21 - PR Newswire

Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources?

Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources? PR Newswire

13.09.21 - PR Newswire

Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International?

Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International? PR Newswire

09.09.21 - Der Aktionär

Roche‑Tochter Genentech lässt Adaptimmune‑Aktie fliegen – dieser AKTIONÄR‑Hot‑Stock profitiert vom Top‑Deal

07.09.21 - PR Newswire

Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?

Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire

20.05.21 - PR Newswire

Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio?

Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio? PR Newswire

02.06.20 - PR Newswire

Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?

Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis? PR Newswire

12.05.20 - PR Newswire

Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-Diagnostics, or Delta Air Lines?

Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-Diagnostics, or Delta Air Lines? PR Newswire

13.02.19 - Der Aktionär

Medigene-Rivale Adaptimmune: "Wir lernen ständig mehr darüber"

17.01.18 - Der Aktionär

Biotech-Szene im Übernahmefieber: Fantasie bei Bluebird Bio, Medigene und Co

08.01.18 - GlobeNewswire

Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company

Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company Successful Manufacturing of SPEAR T-...

06.11.17 - GlobeNewswire

Adaptimmune marks Official Opening of U.K. Headquarters

Adaptimmune marks Official Opening of U.K. Headquarters Flagship Facility is new Base for U.K. Research and Development Operations PHILADELPHIA and OXFORD, U.K., Nov. ...

07.09.17 - GlobeNewswire

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune ...

27.03.17 - GlobeNewswire

Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares

Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares PHILADELPHIA and ...

22.03.17 - GlobeNewswire

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares PHILADELPHIA and OXFORD, United Kingdom, March 22, 2017 (GLOBE NEWSWIRE) -- ...

Newssuche

Videos

06.06.24 +3,57%

Technical Trading: Erdgas nach Rücksetzer Long

Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Weitere Videos